Table 2.
Gene | Diseases | Molecular defects | Phenotypes | Refs |
---|---|---|---|---|
NSD1 | Sotos syndrome | Haploinsufficiency, point mutations, deletions, translocations | Macrocephaly, hypertolerism, cognitive and/or motor skill deficiencies | 98 |
NSD1 | Myelodysplastic syndrome | Translocations | Anaemia, cytopenia | 111 |
NSD1 | Cancers: AML, prostate, neuroblastoma, breast | Overexpression, gene silencing, translocations | Numerous tumour types | 19,78,101, 110,112 |
NSD2 | Wolf–Hirschhorn syndrome | Deletions | Learning difficulties, microcephaly, heart defects | 32 |
NSD2 | Multiple myeloma | t(4;14)+ translocation | Renal failure, anaemia, bone lesions | 30,115 |
NSD3 | Breast cancer | Gene amplification at 8p11 | Solid tumours | 107 |
NSD3 | AML | Translocations | Leukaemic cells in bone marrow | 105 |
NSD3 | Myelodysplastic syndrome | Translocations | Anaemia, cytopenia | 106 |
SETD2 | Renal cell carcinoma | Deletions, missense mutations | Haematuria, flank pain | 99 |
The table lists the known diseases resulting from alterations in the genes encoding enzymes that are specific for Lys36 on histone H3 (H3K36). AML, acute myeloid leukaemia; NSD, nuclear receptor SET domain-containing; SETD2, SET domain-containing 2.